drugset / Trial / NCT04447534
Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19
RandomizedParallel-groupDouble-blindTreatment
Summary
we want to investigate if zinc supplementation enhance the clinical efficacy of chloroquine in treatment of COVID-19.
Timeline
- Start
- 2020-06-23
- Primary completion
- 2020-07-15
- Completion
- 2020-08-15
Outcome
Missed primary endpoint
paper Clinical recovery after 28 days was achieved by 79.2% in the zinc group and 77.9% in zinc-free treatment group, without any significant difference (p = 0.969). PMID 33247380 ↗
paper The need for mechanical ventilation and the overall mortality rates did not show any significant difference between the 2 groups either (p = 0.537 and 0.986, respectively). PMID 33247380 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Chloroquine | Small molecule | — | — |
| Subject | Hydroxychloroquine | Small molecule | — | — |
| Subject | Zinc Sulfate | Unknown | — | — |